HSR&D Citation Abstract
Search | Search by Center | Search by Source | Keywords in Title
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer.
Singhal U, Skolarus TA, Gore JL, Parry MG, Chen RC, Nossiter J, Paniagua-Cruz A, George AK, Cathcart P, Meulen JV, Wittmann DA. Implementation of patient-reported outcome measures into health care for men with localized prostate cancer. Nature reviews. Urology. 2022 May 1; 19(5):263-279.
Measuring treatment-related quality of life (QOL) has become an increasingly requisite component of delivering high-quality care for patients with prostate cancer. Patient-reported outcome measures (PROMs) have, therefore, become an important tool for understanding the adverse effects of radical prostate cancer treatment and have been widely integrated into clinical practice. By providing real-time symptom monitoring and improved clinical feedback to patients and providers, PRO assessment has led to meaningful gains in prostate cancer care delivery and quality improvement worldwide. By providing an avenue for benchmarking, collaboration and population health monitoring, PROMs have delivered substantial improvements beyond providing individual symptom feedback. However, multilevel barriers exist that need to be addressed before the routine implementation of PROMs is achieved. Improvements in collection, interpretation, standardization and reporting will be crucial for the continued implementation of PROM instruments in prostate cancer pathways.